{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T04:45:35Z","timestamp":1782621935990,"version":"3.54.5"},"reference-count":127,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Membranes"],"abstract":"<jats:p>Despite its established role as a cornerstone of chemotherapy for solid tumors, 5-Fluorouracil (5-FU) clinical efficacy remains limited by chemoresistance and heterogeneous drug response. Traditional explanations have focused on intracellular metabolism and genetic determinants; however, increasing evidence identifies the plasma membrane as a critical regulatory interface controlling drug availability, signaling integration, and cell fate. Here, we propose a membrane-centered framework in which compartmentalized cAMP\/PKA signaling, modulated by repurposed vasoregulatory agents\u2014levosimendan, milrinone, and terbutaline\u2014enhances 5-FU response by functionally remodeling the cancer cell membrane. This remodeling may influence lipid raft organization, ENT1\/SLC29A1 transporter trafficking, and the balance between drug influx and efflux, increasing intracellular 5-FU bioavailability and overcoming membrane-mediated pseudo-resistance. In parallel, cAMP-dependent signaling may modulate redox homeostasis, mitochondria-associated membranes, and apoptotic threshold regulation, shifting the cellular response toward irreversible cell death. Importantly, this framework is reconciled with canonical resistance mechanisms\u2014including TYMS upregulation, DPD overexpression, and MMR deficiency\u2014positioning membrane phenotype as a functionally upstream regulatory layer. Differential sensitivity observed experimentally in bladder versus prostate cancer models supports the concept of integrated membrane phenotype biomarkers. Clinical translation requires rigorous pharmacokinetic\u2013pharmacodynamic validation and cardiovascular safety assessment. Redefining the plasma membrane as a dynamic therapeutic interface may provide a rationale for drug repurposing, patient stratification, and personalized combination strategies.<\/jats:p>","DOI":"10.3390\/membranes16070217","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:43:57Z","timestamp":1782463437000},"page":"217","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repurposed cAMP-Modulating Agents Enhance 5-Fluorouracil Response Through Membrane-Dependent Mechanisms"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5370-9586","authenticated-orcid":false,"given":"Eduarda","family":"Ribeiro","sequence":"first","affiliation":[{"name":"PerMed Research Group, RISE-Health, Faculty of Medicine, University of Porto, Alameda Professor Hernani Monteiro, 4200-319 Porto, Portugal"},{"name":"ICBAS\u2014School of Medicine and Biomedical Sciences, University of Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1283-1042","authenticated-orcid":false,"given":"Nuno","family":"Vale","sequence":"additional","affiliation":[{"name":"PerMed Research Group, RISE-Health, Faculty of Medicine, University of Porto, Alameda Professor Hernani Monteiro, 4200-319 Porto, Portugal"},{"name":"RISE-Health, Department of Community Medicine, Health Information and Decision (MEDCIDS), Faculty of Medicine, University of Porto, Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"Laboratory of Personalized Medicine, Department of Community Medicine, Health Information and Decision (MEDCIDS), Faculty of Medicine, University of Porto, Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ghafouri-Fard, S., Abak, A., Tondro Anamag, F., Shoorei, H., Fattahi, F., Javadinia, S.A., Basiri, A., and Taheri, M. (2021). 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.658636"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"107447","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/acsptsci.2c00117","article-title":"Dihydropyrimidine Dehydrogenase-Mediated Resistance to 5-Fluorouracil: Mechanistic Investigation and Solution","volume":"5","author":"Verma","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_4","unstructured":"Bentley, P.J. (1981). Roles of the cell membrane in responses to drugs. Elements of Pharmacology: A Primer on Drug Action, Cambridge University Press."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3109\/03639045.2011.559658","article-title":"Study on hydrophilic 5-fluorouracil release from hydrophobic poly(\u03b5-caprolactone) cylindrical implants","volume":"37","author":"Hou","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11051-023-05885-1","article-title":"Molecular dynamics simulations of hydrophilic pores in phospholipid bilayers and Fe3O4 nanoparticles loaded with the 5-fluorouracil anticancer drug","volume":"25","author":"Harris","year":"2023","journal-title":"J. Nanopart. Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Pisco, A.O., Jackson, D.A., and Huang, S. (2014). Reduced Intracellular Drug Accumulation in Drug-Resistant Leukemia Cells is Not Only Solely Due to MDR-Mediated Efflux but also to Decreased Uptake. Front. Oncol., 4.","DOI":"10.3389\/fonc.2014.00306"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ribeiro, E., and Vale, N. (2026). Personalized Combination Therapy in Bladder Cancer: cAMP Modulators Synergize with 5-FU and Modulate Redox Programs. Cancers, 18.","DOI":"10.3390\/cancers18040562"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ribeiro, E., and Vale, N. (2024). Novel Drug Combinations in Lung Cancer: New Potential Synergies Between 5-FU and Repurposed Drugs. Appl. Sci., 14.","DOI":"10.3390\/app14219658"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ribeiro, E., Costa, B., Marques, L., Vasques-N\u00f3voa, F., and Vale, N. (2024). Enhancing Urological Cancer Treatment: Leveraging Vasodilator Synergistic Potential with 5-FU for Improved Therapeutic Outcomes. J. Clin. Med., 13.","DOI":"10.3390\/jcm13144113"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.jacc.2012.01.060","article-title":"Cyclic Adenosine Monophosphate Phosphodiesterase Type 4 Protects Against Atrial Arrhythmias","volume":"59","author":"Molina","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","first-page":"e10636","article-title":"Cyclic Adenosine Monophosphate (cAMP) Dependent Phosphodiesterase Inhibition Promotes Bone Anabolism Through CD8+ T Cell Wnt 10b Production in Mice","volume":"6","author":"Weiss","year":"2022","journal-title":"J. Bone Miner. Res. Plus"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"C181","DOI":"10.1152\/ajpcell.00087.2015","article-title":"The plasma membrane as a capacitor for energy and metabolism","volume":"310","author":"Ray","year":"2016","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1095-6433(98)10004-1","article-title":"Cell membranes; barriers, regulators and transducers?","volume":"120","author":"Simkiss","year":"1998","journal-title":"Comp. Biochem. Physiol. Part A Mol. Integr. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ctrv.2016.10.008","article-title":"Cell membrane modulation as adjuvant in cancer therapy","volume":"52","author":"Zalba","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12944-025-02563-0","article-title":"Lipid rafts: Novel therapeutic targets for metabolic, neurodegenerative, oncological, and cardiovascular diseases","volume":"24","author":"Warda","year":"2025","journal-title":"Lipids Health Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/09687680410001700517","article-title":"Plasma membrane microdomains: Organization, function and trafficking","volume":"21","author":"Laude","year":"2004","journal-title":"Mol. Membr. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1039\/D3SC04523D","article-title":"The intricate link between membrane lipid structure and composition and membrane structural properties in bacterial membranes","volume":"15","author":"Lee","year":"2024","journal-title":"Chem. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Choroma\u0144ska, A., Chwi\u0142kowska, A., Kulbacka, J., Baczy\u0144ska, D., Rembia\u0142kowska, N., Szewczyk, A., Michel, O., Gajewska-Naryniecka, A., Przystupski, D., and Saczko, J. (2021). Modifications of Plasma Membrane Organization in Cancer Cells for Targeted Therapy. Molecules, 26.","DOI":"10.3390\/molecules26071850"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1054-3589(10)58004-9","article-title":"Mechanisms of GABAB Receptor Exocytosis, Endocytosis, and Degradation","volume":"Volume 58","author":"Blackburn","year":"2010","journal-title":"Advances in Pharmacology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.molonc.2009.05.008","article-title":"Endocytosis and spatial restriction of cell signaling","volume":"3","author":"Disanza","year":"2009","journal-title":"Mol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1021\/acs.chemrev.7b00678","article-title":"Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts","volume":"118","author":"Stewart","year":"2018","journal-title":"Chem. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e1136374","DOI":"10.1080\/21592799.2015.1136374","article-title":"Plasma membrane regulates Ras signaling networks","volume":"5","author":"Chavan","year":"2015","journal-title":"Cell. Logist."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tox.2012.12.014","article-title":"Role for membrane remodeling in cell death: Implication for health and disease","volume":"304","author":"Tekpli","year":"2013","journal-title":"Toxicology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1038\/sj.bjp.0707656","article-title":"Kinetics of G-protein-coupled receptor signals in intact cells","volume":"153","author":"Lohse","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"026013","DOI":"10.1117\/1.3540670","article-title":"Terbutaline causes immobilization of single \u03b22-adrenergic receptor-ligand complexes in the plasma membrane of living A549 cells as revealed by single-molecule microscopy","volume":"16","author":"Sieben","year":"2011","journal-title":"J. Biomed. Opt."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pharmthera.2014.03.008","article-title":"cAMP signaling in subcellular compartments","volume":"143","author":"Lefkimmiatis","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm1447","article-title":"Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma","volume":"12","author":"Thaker","year":"2006","journal-title":"Nat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12964-021-00755-6","article-title":"Role of \u03b1- and \u03b2-adrenergic signaling in phenotypic targeting: Significance in benign and malignant urologic disease","volume":"19","author":"Archer","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"44732","DOI":"10.18632\/oncotarget.17267","article-title":"Catecholamines facilitate VEGF-dependent angiogenesis via \u03b22-adrenoceptor-induced Epac1 and PKA activation","volume":"8","author":"Garg","year":"2017","journal-title":"Oncotarget"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cas.14670","article-title":"Activation of \u03b22-adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells","volume":"112","author":"Sakakitani","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCRESAHA.106.144501","article-title":"cAMP and cGMP signaling cross-talk: Role of phosphodiesterases and implications for cardiac pathophysiology","volume":"100","author":"Zaccolo","year":"2007","journal-title":"Circ. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"12331","DOI":"10.1074\/jbc.275.16.12331","article-title":"Functions of the N-terminal region of cyclic nucleotide phosphodiesterase 3 (PDE 3) isoforms","volume":"275","author":"Kenan","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.coph.2011.10.006","article-title":"Role of PDE3A in regulation of cell cycle progression in mouse vascular smooth muscle cells and oocytes: Implications in cardiovascular diseases and infertility","volume":"11","author":"Begum","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.RES.0000258451.44949.d7","article-title":"Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart","volume":"100","author":"Yan","year":"2007","journal-title":"Circ. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1158\/0008-5472.CAN-07-0097","article-title":"Chemoresistant KM12C colon cancer cells are addicted to low cyclic AMP levels in a phosphodiesterase 4-regulated compartment via effects on phosphoinositide 3-kinase","volume":"67","author":"McEwan","year":"2007","journal-title":"Cancer Res."},{"key":"ref_38","first-page":"1905","article-title":"PDE3A inhibitor anagrelide activates death signaling pathway genes and synergizes with cell death-inducing cytokines to selectively inhibit cancer cell growth","volume":"9","author":"An","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bcp.2009.09.001","article-title":"Inhibition of PDE3, PDE4 and PDE7 potentiates glucocorticoid-induced apoptosis and overcomes glucocorticoid resistance in CEM T leukemic cells","volume":"79","author":"Dong","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1469-7793.1998.235bi.x","article-title":"Protein kinase A induces recruitment of active Na+,K+-ATPase units to the plasma membrane of rat proximal convoluted tubule cells","volume":"511","author":"Carranza","year":"1998","journal-title":"J. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5114\/aoms.2018.77055","article-title":"Levosimendan in the modern treatment of patients with acute heart failure of various aetiologies","volume":"17","author":"Glinka","year":"2021","journal-title":"Arch. Med. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.cardfail.2004.06.274","article-title":"Levosimendan activates mitochondrial ATP-sensitive potassium channels","volume":"10","author":"Pollesello","year":"2004","journal-title":"J. Card. Fail."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.yjmcc.2004.12.003","article-title":"Mitochondrial K(ATP) channels in cell survival and death","volume":"39","author":"Ardehali","year":"2005","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11010-009-0283-2","article-title":"Opening of the mitoKATP channel and decoupling of mitochondrial complex II and III contribute to the suppression of myocardial reperfusion hyperoxygenation","volume":"337","author":"Liu","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"H960","DOI":"10.1152\/ajpheart.00858.2012","article-title":"Mitochondrial reactive oxygen species: Which ROS signals cardioprotection?","volume":"305","author":"Garlid","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41401-024-01359-9","article-title":"The correlation between mitochondria-associated endoplasmic reticulum membranes (MAMs) and Ca2+ transport in the pathogenesis of diseases","volume":"46","author":"Zhao","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Agarwal, S.R., Gratwohl, J., Cozad, M., Yang, P.C., Clancy, C.E., and Harvey, R.D. (2018). Compartmentalized cAMP Signaling Associated With Lipid Raft and Non-raft Membrane Domains in Adult Ventricular Myocytes. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00332"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Raker, V.K., Becker, C., and Steinbrink, K. (2016). The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00123"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","article-title":"The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)","volume":"40","author":"Ardito","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1021\/bi990064q","article-title":"The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter","volume":"38","author":"Romsicki","year":"1999","journal-title":"Biochemistry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/science.1174621","article-title":"Lipid rafts as a membrane-organizing principle","volume":"327","author":"Lingwood","year":"2010","journal-title":"Science"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e2400732121","DOI":"10.1073\/pnas.2400732121","article-title":"cAMP\/PKA signaling regulates TDP-43 aggregation and mislocalization","volume":"121","author":"Ho","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2016.05.003","article-title":"Loops and layers of post-translational modifications of drug transporters","volume":"116","author":"Xu","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"10934","DOI":"10.1074\/jbc.M115.701201","article-title":"Importance of a Potential Protein Kinase A Phosphorylation Site of Na+,K+-ATPase and Its Interaction Network for Na+ Binding","volume":"291","author":"Einholm","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"102378","DOI":"10.1016\/j.sbi.2022.102378","article-title":"Recent advances on the inhibition of human solute carriers: Therapeutic implications and mechanistic insights","volume":"74","author":"Wright","year":"2022","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_56","first-page":"2241","article-title":"Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer","volume":"27","author":"Tsujie","year":"2007","journal-title":"Anticancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"115741","DOI":"10.1016\/j.bcp.2023.115741","article-title":"Nucleoside-based anticancer drugs: Mechanism of action and drug resistance","volume":"215","author":"Hruba","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/j.gastro.2008.09.067","article-title":"Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer","volume":"136","author":"Farrell","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/15257770.2016.1210805","article-title":"Equilibrative nucleoside transporters\u2014A review","volume":"36","author":"Hays","year":"2017","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref_60","first-page":"4349","article-title":"Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines","volume":"58","author":"Mackey","year":"1998","journal-title":"Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1124\/mol.59.6.1542","article-title":"Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[Prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug","volume":"59","author":"Mata","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pharmthera.2018.06.013","article-title":"Post-translational modifications of transporters","volume":"192","author":"Czuba","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Cao, Y., Rao, C., and Du, Z. (2026). The SLC41 Family of Magnesium Transporters: Molecular Regulators of Magnesium Homeostasis and Their Multifaceted Roles in Human Diseases. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27041673"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1194\/jlr.TR119000468","article-title":"Lipid rafts in glial cells: Role in neuroinflammation and pain processing: Thematic Review Series: Biology of Lipid Rafts","volume":"61","author":"Miller","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Ristovski, M., Farhat, D., Bancud, S.E.M., and Lee, J.-Y. (2021). Lipid Transporters Beam Signals from Cell Membranes. Membranes, 11.","DOI":"10.20944\/preprints202107.0244.v1"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"100002","DOI":"10.1016\/j.celld.2026.100002","article-title":"Endoplasmic reticulum\u2014Mitochondrial crosstalk at MAMs: Shaping cancer metabolism and cell death decisions","volume":"2","author":"Pandey","year":"2026","journal-title":"Cell Death"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13045-024-01524-x","article-title":"cAMP-PKA\/EPAC signaling and cancer: The interplay in tumor microenvironment","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"34","DOI":"10.33393\/dti.2020.2185","article-title":"Interaction of drugs with lipid raft membrane domains as a possible target","volume":"14","author":"Tsuchiya","year":"2020","journal-title":"Drug Target Insights"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00210-021-02112-3","article-title":"Acquired ABC-transporter overexpression in cancer cells: Transcriptional induction or Darwinian selection?","volume":"394","author":"Theile","year":"2021","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1128\/MMBR.00001-07","article-title":"Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria","volume":"71","author":"Lubelski","year":"2007","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/humu.24418","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"43","author":"Dean","year":"2022","journal-title":"Hum. Mutat."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3892\/ijo.2023.5567","article-title":"Mechanism of multidrug resistance to chemotherapy mediated by P-glycoprotein (Review)","volume":"63","author":"Tian","year":"2023","journal-title":"Int. J. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Linke, D., Donix, L., Peitzsch, C., Erb, H.H.H., Dubrovska, A., Pfeifer, M., Thomas, C., Fuessel, S., and Erdmann, K. (2022). Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010666"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/iep.12212","article-title":"Hypermethylation of ATP-binding cassette B1 (ABCB1) multidrug resistance 1 (MDR1) is associated with cisplatin resistance in the A549 lung adenocarcinoma cell line","volume":"97","author":"Li","year":"2016","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1592\/phco.26.11.1601","article-title":"Role of P-glycoprotein in statin drug interactions","volume":"26","author":"Holtzman","year":"2006","journal-title":"Pharmacotherapy"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Sharom, F.J. (2014). Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function. Front. Oncol., 4.","DOI":"10.3389\/fonc.2014.00041"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2004.06.026","article-title":"Predicting drug sensitivity and resistance: Profiling ABC transporter genes in cancer cells","volume":"6","author":"Annereau","year":"2004","journal-title":"Cancer Cell"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1389450033347172","article-title":"Lipids as a target for drugs modulating multidrug resistance of cancer cells","volume":"4","author":"Hendrich","year":"2003","journal-title":"Curr. Drug Targets"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-cancerbio-041916-065808","article-title":"The Two Faces of Reactive Oxygen Species in Cancer","volume":"1","author":"Reczek","year":"2017","journal-title":"Annu. Rev. Cancer Biol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Nigam, M., Punia, B., Dimri, D.B., Mishra, A.P., Radu, A.-F., and Bungau, G. (2025). Reactive Oxygen Species: A Double-Edged Sword in the Modulation of Cancer Signaling Pathway Dynamics. Cells, 14.","DOI":"10.3390\/cells14151207"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrm3801","article-title":"Cellular mechanisms and physiological consequences of redox-dependent signalling","volume":"15","author":"Finkel","year":"2014","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4161\/oxim.2.5.9657","article-title":"cAMP activates the generation of reactive oxygen species and inhibits the secretion of IL-6 in peripheral blood mononuclear cells from type 2 diabetic patients","volume":"2","author":"Isoni","year":"2009","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4062\/biomolther.2022.017","article-title":"Modulation of Reactive Oxygen Species to Overcome 5-Fluorouracil Resistance","volume":"30","author":"Chun","year":"2022","journal-title":"Biomol. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/2211-5463.70121","article-title":"Mitochondria-associated membranes (MAMs): Molecular organization, cellular functions, and their role in health and disease","volume":"16","author":"Bui","year":"2026","journal-title":"FEBS Open Bio"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Mustafa, M., Ahmad, R., Tantry, I.Q., Ahmad, W., Siddiqui, S., Alam, M., Abbas, K., Hassan, M.I., and Habib, S. (2024). Apoptosis: A Comprehensive Overview of Signaling Pathways, Morphological Changes, and Physiological Significance and Therapeutic Implications. Cells, 13.","DOI":"10.3390\/cells13221838"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ceca.2017.01.007","article-title":"Crosstalk between calcium and reactive oxygen species signaling in cancer","volume":"63","author":"Hempel","year":"2017","journal-title":"Cell Calcium"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/B978-0-12-407704-1.00005-1","article-title":"Endoplasmic reticulum and the unfolded protein response: Dynamics and metabolic integration","volume":"301","author":"Bravo","year":"2013","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Gawlak-Socka, S., Kowalczyk, E., and Wiktorowska-Owczarek, A. (2026). Unfolded Protein Response at the Crossroads: Integrating Endoplasmic Reticulum Stress with Cellular Stress Networks. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27041986"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Kim, K.H., and Yoo, B.C. (2026). Decoding Membrane Lipids: Analytical Barriers and Technological Advances in Modern Lipidomics. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27031472"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biochi.2011.09.025","article-title":"Lipid peroxidation modifies the picture of membranes from the \u201cFluid Mosaic Model\u201d to the \u201cLipid Whisker Model\u201d","volume":"94","year":"2012","journal-title":"Biochimie"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Zayani, Z., Matinahmadi, A., Tavakolpournegari, A., and Bidooki, S.H. (2025). Exploring Stressors: Impact on Cellular Organelles and Implications for Cellular Functions. Stresses, 5.","DOI":"10.3390\/stresses5020026"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Iliadis, S., and Papanikolaou, N.A. (2024). Reactive Oxygen Species Mechanisms that Regulate Protein-Protein Interactions in Cancer. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202408.1413.v1"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5732\/cjc.011.10466","article-title":"Role of ABC transporters in cancer chemotherapy","volume":"31","author":"Sun","year":"2012","journal-title":"Chin. J. Cancer"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpha.2020.04.001","article-title":"Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method","volume":"11","author":"Machon","year":"2021","journal-title":"J. Pharm. Anal."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"10196","DOI":"10.1038\/s41598-026-41179-x","article-title":"Enhancing 5-fluorouracil efficacy in colorectal cancer by inhibiting glutathione antioxidant mechanisms with an xCT inhibitor","volume":"16","author":"Akar","year":"2026","journal-title":"Sci. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"(2015). 5Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stemlike traits. Oncotarget, 6, 41706.","DOI":"10.18632\/oncotarget.5991"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1748-1716.2011.02273.x","article-title":"Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger","volume":"204","author":"Insel","year":"2012","journal-title":"Acta Physiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1161\/01.RES.85.11.985","article-title":"Distinct Role of cAMP and cGMP in the Cell Cycle Control of Vascular Smooth Muscle Cells","volume":"85","author":"Fukumoto","year":"1999","journal-title":"Circ. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/sj.onc.1201038","article-title":"Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts","volume":"14","author":"Lavoie","year":"1997","journal-title":"Oncogene"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1091\/mbc.e04-06-0501","article-title":"cAMP-mediated inhibition of DNA replication and S phase progression: Involvement of Rb, p21Cip1, and PCNA","volume":"16","author":"Naderi","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Chen, J.K., Merrick, K.A., Kong, Y.W., Izrael-Tomasevic, A., Eng, G., Handly, E.D., Patterson, J.C., Cannell, I.G., Suarez-Lopez, L., and Hosios, A.M. (2023). An RNA Damage Response Network Mediates the Lethality of 5-FU in Clinically Relevant Tumor Types. bioRxiv.","DOI":"10.1101\/2023.04.28.538590"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.semcdb.2023.07.003","article-title":"Shedding light on mitochondrial outer-membrane permeabilization and membrane potential: State of the art methods and biosensors","volume":"156","author":"Popgeorgiev","year":"2024","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1038\/ncomms7169","article-title":"Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity","volume":"6","author":"Majumder","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tem.2012.06.009","article-title":"Genetically-defined metabolic reprogramming in cancer","volume":"23","author":"Mullen","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Puris, E., Fricker, G., and Gynther, M. (2023). The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15020364"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Zhang, W., Liu, Q.Y., Haqqani, A.S., Liu, Z., Sodja, C., Leclerc, S., Baumann, E., Delaney, C.E., Brunette, E., and Stanimirovic, D.B. (2023). Differential Expression of ABC Transporter Genes in Brain Vessels vs. Peripheral Tissues and Vessels from Human, Mouse and Rat. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15051563"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Park, M.N., Choi, M., Syahputra, R.A., Delfino, D.V., Ko, S.G., and Kim, B. (2026). Redox Homeostasis as a Therapeutic Target in Chronic Oxidative Diseases: Implications for Cancer Treatment. Antioxidants, 15.","DOI":"10.3390\/antiox15020203"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.3390\/ijms10041911","article-title":"Heterogeneity of mitochondria and mitochondrial function within cells as another level of mitochondrial complexity","volume":"10","author":"Kuznetsov","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0928-4680(00)00053-5","article-title":"Oxidative stress and apoptosis","volume":"7","author":"Kannan","year":"2000","journal-title":"Pathophysiology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0925-4439(02)00082-0","article-title":"Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism","volume":"1587","author":"Peters","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"257","DOI":"10.20517\/cdr.2022.136","article-title":"Review of 5-FU resistance mechanisms in colorectal cancer: Clinical significance of attenuated on-target effects","volume":"6","author":"Gmeiner","year":"2023","journal-title":"Cancer Drug Resist."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s13167-010-0041-2","article-title":"Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: Ready for routine clinical application within personalized medicine?","volume":"1","author":"Bocci","year":"2010","journal-title":"EPMA J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s10147-003-0330-z","article-title":"Clinical implications of dihydropyrimidine dehydrogenase (DPD) activity in 5-FU-based chemotherapy: Mutations in the DPD gene, and DPD inhibitory fluoropyrimidines","volume":"8","author":"Omura","year":"2003","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4161\/cbt.12.8.17169","article-title":"DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells","volume":"12","author":"Iwaizumi","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"19577","DOI":"10.1038\/srep19577","article-title":"Mechanisms Restricting Diffusion of Intracellular cAMP","volume":"6","author":"Agarwal","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1158\/1541-7786.MCR-17-0686","article-title":"Thymidine Kinase 1 Loss Confers Trifluridine Resistance without Affecting 5-Fluorouracil Metabolism and Cytotoxicity","volume":"16","author":"Edahiro","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3892\/ol.2022.13431","article-title":"The mechanism underlying resistance to 5-fluorouracil and its reversal by the inhibition of thymidine phosphorylase in breast cancer cells","volume":"24","author":"Mori","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1096\/fba.2022-00099","article-title":"Regulation of 5-fluorodeoxyuridine monophosphate-thymidylate synthase ternary complex levels by autophagy confers resistance to 5-fluorouracil","volume":"5","author":"Nishizawa","year":"2023","journal-title":"FASEB BioAdvances"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1002\/mco2.265","article-title":"Understanding and targeting resistance mechanisms in cancer","volume":"4","author":"Lei","year":"2023","journal-title":"MedComm"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1254\/jphs.10031FP","article-title":"Noradrenaline induces clock gene Per1 mRNA expression in C6 glioma cells through beta(2)-adrenergic receptor coupled with protein kinase A\u2014cAMP response element binding protein (PKA-CREB) and Src-tyrosine kinase\u2014glycogen synthase kinase-3beta (Src-GSK-3beta)","volume":"113","author":"Morioka","year":"2010","journal-title":"J. Pharmacol. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"113391","DOI":"10.1016\/j.biopha.2022.113391","article-title":"The importance of pharmacokinetics, pharmacodynamic and repetitive use of levosimendan","volume":"153","author":"Rogowicz","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Ribeiro, E., and Vale, N. (2023). Understanding the Clinical Use of Levosimendan and Perspectives on its Future in Oncology. Biomolecules, 13.","DOI":"10.3390\/biom13091296"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Ribeiro, E., and Vale, N. (2025). Repurposing Terbutaline and Milrinone for Cancer Therapy: A Comprehensive Review. Future Pharmacol., 5.","DOI":"10.3390\/futurepharmacol5030038"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Qiao, G., Chen, M., Bucsek, M.J., Repasky, E.A., and Hylander, B.L. (2018). Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00164"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"10063","DOI":"10.1038\/s41467-025-65048-9","article-title":"\u03b2-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells","volume":"16","author":"Johansen","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mayocp.2025.08.019","article-title":"Cardiovascular Toxicity of Fluoropyrimidines: What We Know","volume":"101","author":"Zalaquett","year":"2026","journal-title":"Mayo Clin. Proc."}],"container-title":["Membranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0375\/16\/7\/217\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T04:14:56Z","timestamp":1782620096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0375\/16\/7\/217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":127,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["membranes16070217"],"URL":"https:\/\/doi.org\/10.3390\/membranes16070217","relation":{},"ISSN":["2077-0375"],"issn-type":[{"value":"2077-0375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}